Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interpreting survival differences and trends

F Berrino1, A Micheli, M Sant

  • 1Divisione di Epidemiologia, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy. INTEPI@ICIL64.CILEA.IT

Tumori
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Machine learning prediction of mechanical dilatation in transvenous lead extraction for cardiac device-related infections: insights from a high-volume centre.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2026
Same author

Patients with cancer who will be cured and projections of complete prevalence in Italy from 2018 to 2030.

ESMO open·2024
Same author

Mammographic density to predict response to neoadjuvant systemic breast cancer therapy.

Journal of cancer research and clinical oncology·2022
Same author

Older age and comorbidity in breast cancer: is RT alone the new therapeutic frontier?

Journal of cancer research and clinical oncology·2020
Same author

Axillary nodal involvement by primary tumor features in early breast cancer: an analysis of 2600 patients.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2019
Same author

The European study on centralisation of childhood cancer treatment.

European journal of cancer (Oxford, England : 1990)·2019
Same journal

End-of-life decisions and opinions: Results of E.L.D.Y.-CA.RE study carried out at Veneto Institute of Oncology, Italy.

Tumori·2026
Same journal

Quality indicators in identification and care of patients with genetic predisposition to cancer: An AIFET proposal.

Tumori·2026
Same journal

Driver vs. passenger: Primary resistance to larotrectinib in synovial sarcoma harboring concurrent SS18 rearrangement and PDE3A-NTRK2 fusion.

Tumori·2026
Same journal

Beyond the calendar: A narrative review on chronobiological drivers of prognosis in resectable NSCLC.

Tumori·2026
Same journal

Challenging the cornerstone: Toward risk-adapted follow-up in early breast cancer.

Tumori·2026
Same journal

Assessing in house comprehensive genomic profiling by liquid biopsy for NSCLC patients.

Tumori·2026
See all related articles

European cancer registries (EUROCARE project) found survival differences for breast, stomach, and colon cancer. Survival rates are converging across Europe, but interpreting these trends requires careful consideration of diagnosis and treatment factors.

Area of Science:

  • Epidemiology
  • Public Health
  • Cancer Research

Background:

  • The EUROCARE project, a collaboration of European population-based cancer registries since 1990, investigates cancer patient survival variations across Europe.
  • Significant survival differences exist for cancers where diagnosis stage is a key prognostic factor, including breast, stomach, and colon cancer.

Purpose of the Study:

  • To identify differences in cancer patient survival across European countries.
  • To explore the underlying reasons for observed survival disparities.
  • To analyze trends in cancer survival and factors influencing them.

Main Methods:

  • Analysis of population-based cancer registry data from multiple European countries.
  • Comparison of survival rates for various cancer sites, considering stage at diagnosis.

Related Experiment Videos

  • Development and application of statistical approaches, including multivariate analysis and new modeling techniques, to disentangle effects of diagnosis and treatment.

    • Main Results:

    • Cancer patient survival rates are increasing over time and converging across different European countries for most cancer sites.
    • Survival differences persist for cancers strongly influenced by diagnostic stage, such as breast, stomach, and colon cancer.
    • Interpreting survival trends is complex, influenced by factors like early diagnosis, treatment effectiveness, and data quality.

    Conclusions:

    • While overall cancer survival is improving and converging in Europe, disparities remain for certain cancer types.
    • Accurate interpretation of survival data necessitates accounting for numerous confounding factors, including diagnostic procedures and registry data quality.
    • Advanced statistical methods are crucial for distinguishing the impact of early diagnosis versus treatment efficacy on patient survival.